2008: Treatment and Pharmacosurveillance in RA
Search or Browse by Day

Treatment and Pharmacosurveillance in RA

Monday, October 27, 2008
1262
Leflunomide Increases the Risk for Incident Peripheral Neuropathies in Patients with RA
1263
Drug-Specific Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Anti-TNF Therapy: Results from the BSRBR
1264
The Influence of Anti-TNF Therapy upon Cancer Incidence in Patients with Rheumatoid Arthritis (RA) who have had Prior Malignancy: Results from the BSRBR
1265
A Randomized Controlled Trial of Ultrasound Versus Clinical Guided Intra-articular Corticosteroid Injection in Inflammatory Arthritis
1266
Is The Exposure To TNF Antagonists A Risk Factor For Cancer In Rheumatoid Arthritis?
1267
The effect of infliximab on antiviral antibody profiles in patients with Rheumatoid Arthritis
See more of: ACR Abstract Submission ACR Concurrent Abstract Session
<< Previous Session Level | Next Session Level >>